YBX1 and breast cancer: We hypothesised that comparable to the breast cancer model, tRF-GlyTCC interacted with YBX1 to blunt a potential oncogenic protein-RNA interaction, though it was undetermined whether this interaction caused apoptosis or reduced cell viability.